Latest Ratings for CHD
DateFirmActionFromTo Mar 2022Atlantic EquitiesDowngradesNeutralUnderweight Feb 2022Argus ResearchDowngradesBuyHold Jan 2022Credit SuisseDowngradesOutperformNeutral
DateFirmActionFromTo Mar 2022Atlantic EquitiesDowngradesNeutralUnderweight Feb 2022Argus ResearchDowngradesBuyHold Jan 2022Credit SuisseDowngradesOutperformNeutral